Hydrochloric Acid

Hydrochloric Acid

SCHEMBL970560

Cc1cc(N)cc(C)c1N.Cl

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 4/20 0.38
ACHE known ✓ P22303 1/20 0.35
ALDH1A1 P00352 9/20 0.61
CYP3A4 P08684 5/20 0.61
TSHR P16473 4/20 0.61
TDP1 Q9NUW8 3/20 0.61
TP53 P04637 2/20 0.61
POLB P06746 1/20 0.57
PDE10A Q9Y233 1/20 0.42
CASP1 P29466 2/20 0.39
MAPT P10636 4/20 0.38
MAPK1 P28482 1/20 0.38
THRB P10828 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NR4A1 P22736 1/20 0.37
PTK2B Q14289 1/20 0.37
KDM4E B2RXH2 3/20 0.36
LMNA P02545 2/20 0.36
ALOX15 P16050 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7931830 1.00 ALDH1A1 (0.61) ALDH1A1CYP3A4TSHRTDP1TP53
SCHEMBL33589 0.97 ALDH1A1 (0.65) ALDH1A1CYP3A4TSHRTDP1TP53
SCHEMBL21596963 0.88 ALDH1A1 (0.57) ALDH1A1CYP3A4TSHRTDP1TP53
SCHEMBL5365577 0.85 CYP3A4 (0.60) ALDH1A1CYP3A4TSHRTDP1TP53
SCHEMBL30724395 0.81 CASP1 (0.48) ALDH1A1CYP3A4TSHRTDP1TP53
SCHEMBL9495198 0.81 CASP1 (0.48) ALDH1A1CYP3A4TSHRTDP1TP53
Hydrochloric Acid SCHEMBL23198661 0.80 ALDH1A1 (0.50) ALDH1A1CYP3A4TSHRTDP1TP53
Hydrochloric Acid SCHEMBL472235 0.80 ALDH1A1 (0.93) ALDH1A1CYP3A4TSHRTDP1TP53
Hydrochloric Acid SCHEMBL28496175 0.80 ALDH1A1 (0.93) ALDH1A1CYP3A4TSHRTDP1TP53
Hydrochloric Acid SCHEMBL4598240 0.80 ALDH1A1 (0.93) ALDH1A1CYP3A4TSHRTDP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110020251-A1 Ultraviolet-Absorbing Compounds AVOCA LLC 2011-01-27 US claimed
EP-0722710-B1 Keratinous fiber oxidation dyeing composition and the dyeing process using this composition OREAL (FR) 1999-10-06 EP claimed
EP-0145513-B1 DERIVATIVES OF DIMETHYL-3-NITRO-4-AMINO-ANILINE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE DYEING OF KERATIN FIBRES L'OREAL (FR) 1988-03-23 EP claimed
US-8673272-B2 Ultraviolet-absorbing compounds ISP INVESTMENTS INC. (US) 2014-03-18 US disclosed
US-20110020251-A1 Ultraviolet-Absorbing Compounds AVOCA LLC 2011-01-27 US disclosed
US-20100143274-A1 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS CIBA CORPORATION (US) 2010-06-10 US disclosed
EP-2120846-A2 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS BASF SE (DE) 2009-11-25 EP disclosed
WO-2008107347-A2 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS BASF SE (CH) 2008-09-12 WO disclosed
CN-1101177-C Composition for oxidation dyeing keratin fibres, containing 2-amino 3-hydroxy pyridine and an oxidation base, and dyeing method OREAL (FR) 2003-02-12 CN disclosed
US-6277156-B1 OXIDATION BASE ARE PARAPHENYLENEDIAMINES, DOUBLE BASES; PYRAZOLO(1,5-A)PYRIMIDINES ORTHO-AMINOPHENOLS; DIAMINOPYRIDINES L'ORéAL S.A. (FR) 2001-08-21 US disclosed
US-5928385-A HAIR DYE GIVING UNIFORM COLOR; OXIDATION DYE PRECURSORS AND ONE OR MORE COUPLERS; MULTICOMPARTMENT DEVICE FOR HOLDING DYE COMPOSITION AND SEPARATE OXIDIZING AGENT L'OREAL (FR) 1999-07-27 US disclosed
CN-1189771-A Oxidation dyeing composition and dyeing process for keratin fibres, comprising 2-amino-3-hydroxypyridine and an oxidation dye OREAL (FR) 1998-08-05 CN disclosed
US-5595573-A Keratin fiber dyeing compositions based on a combination of oxidation dyes and corresponding dyeing processes L'OREAL (FR) 1997-01-21 US disclosed
CN-1138452-A Compsn. for oxidation dyeing of Keratinous fibres, and dyeing process using this compsn. OREAL (FR) 1996-12-25 CN disclosed
CN-1138453-A Composition of oxidation dyeing of kerationous fibres, and dyeing process using this composition OREAL (FR) 1996-12-25 CN disclosed
US-4736067-A DIRECT AND OXIDATION HAIR DYES L'OREAL (FR) 1988-04-05 US disclosed
US-4702863-A Indoaniline and indophenol compounds, a process for their preparation, dyeing compositions containing them and a hair-dyeing process L'OREAL (FR) 1987-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100143274-A1 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS MAOA, MAOB, ACMSD GAA 999/4885ACHE 1483/4885ALDH1A1 464/4885
US-20110020251-A1 Ultraviolet-Absorbing Compounds UFM1, UHRF1, CUTA GAA 4597/4885ACHE 3105/4885ALDH1A1 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.